Status:
COMPLETED
Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction
Lead Sponsor:
Novartis
Conditions:
Hypertension
Dyslipidemia
Eligibility:
All Genders
30-65 years
Phase:
PHASE4
Brief Summary
Patients with mild to moderate hypertension, dyslipidemia (imbalanced blood lipids) and decreased vascular dilatation, receiving a cholesterol lowering diet were given either valsartan or fluvastatin ...
Eligibility Criteria
Inclusion
- Arterial hypertension
- Dyslipidemia
- Cholesterol lowering diet
Exclusion
- Constant antihypertensive treatment
- Diabetes mellitus
- Myocardial infarction or stroke in the previous 3 months
- Other inclusion and exclusion criteria may apply
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2005
Estimated Enrollment :
213 Patients enrolled
Trial Details
Trial ID
NCT00171327
Start Date
July 1 2004
End Date
September 1 2005
Last Update
November 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis
Moscow, Russia